Showing results (121-130 of 312) with videos related to

Sort By:
Pageof 32
Acta Pharmaceutica Sinica. B|April 4, 2024
Novel Pt(IV) complex OAP2 induces STING activation and pyroptosis via mitochondrial membrane remodeling for synergistic chemo-immunotherapyRenming Fan, Ruizhuo Lin, Shuo Zhang, et al.
Organic Letters|August 27, 2019
An Acid-Catalyzed Epoxide Ring-Opening/Transesterification Cascade Cyclization to Diastereoselective Syntheses of (±)-β-Noscapine and (±)-β-HydrastineJihui Li, Yongxiang Liu, Xinjing Song, et al.
Bioorganic & Medicinal Chemistry|December 3, 2014
Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitorsShunguang Zhou, Huimin Liao, Mingmei Liu, et al.
European Journal of Medicinal Chemistry|January 11, 2020
Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitorsRuifeng Wang, Sijia Yu, Xiangxin Zhao, et al.
Archiv Der Pharmazie|December 4, 2021
Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitorsYixiang Sun, Ruicheng Lv, Tianxiao Wu, et al.
Physical Chemistry Chemical Physics : PCCP|October 25, 2022
Selectivity mechanism of muscarinic acetylcholine receptor antagonism through in silico investigationLu Chen, Baichun Hu, Hanxun Wang, et al.
Bioorganic Chemistry|July 25, 2020
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking studyRuifeng Wang, Xiangxin Zhao, Sijia Yu, et al.
Archiv Der Pharmazie|July 7, 2020
Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studiesQiaohua Qin, Tianxiao Wu, Wenbo Yin, et al.
Organic Letters|July 30, 2025
Silica Gel-Promoted Tryptamine-Ynamide Cyclization Strategy Enabling Total Synthesis of ElacomineHezhen Han, Shengbo Yin, Hanyang Sun, et al.
Journal of Medicinal Chemistry|March 11, 2026
Discovery and Evaluation of N-Arylindole-Based GluN2B-NMDAR Antagonists with Reduced Cardiotoxicity for the Treatment of Ischemic StrokeZhuo Zhang, Ke Du, Zhenlu Liu, et al.
Pageof 32